| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/16/1998 | WO1998015266A1 Use of bisphenolic compounds to treat type ii diabetes |
| 04/16/1998 | WO1998015264A1 PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF THE HMG-CoA REDUCTASE INHIBITOR FLUVASTATIN |
| 04/16/1998 | WO1998015196A1 Compositions for postgastrectomic mineral supply |
| 04/16/1998 | CA2268874A1 Use of bisphenolic compounds to treat type ii diabetes |
| 04/16/1998 | CA2268284A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | CA2268247A1 Induction of a cellular stress response with heavy metal salts |
| 04/16/1998 | CA2267835A1 1,4-disubstituted piperazines |
| 04/16/1998 | CA2267691A1 N-substituted azaheterocyclic compounds |
| 04/16/1998 | CA2267500A1 N-substituted azaheterocyclic compounds |
| 04/15/1998 | EP0835937A2 Human MYT-1 kinase clone |
| 04/15/1998 | EP0835933A2 A G-protein coupled receptor, HLTEX11 |
| 04/15/1998 | EP0835878A1 Benzo (b) thiophene compounds, intermediates, formulations, and methods |
| 04/15/1998 | EP0835872A1 Benzo [b] thiophene compounds, intermediates, formulations, and methods |
| 04/15/1998 | EP0835871A1 Benzo [b] thiophene compounds, intermediates, formulations, and methods |
| 04/15/1998 | EP0835868A1 2-Aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
| 04/15/1998 | EP0835613A2 Stable emulsions and dry powder from mixtures of fat-soluble vitamins, their process of preparation and their use |
| 04/15/1998 | EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 04/15/1998 | EP0835264A1 Human g-protein receptor hcegh45 |
| 04/15/1998 | EP0835263A2 Somatostatin peptides |
| 04/15/1998 | EP0835262A1 Method for the treatment of corticosteroid induced osteopenia |
| 04/15/1998 | EP0835251A1 Process for the production of lipoic acid |
| 04/15/1998 | EP0835129A1 Prevention of a disease having the characteristics of diabetes |
| 04/15/1998 | EP0835128A1 Use of il-11 to treat inflammation |
| 04/15/1998 | CN1179106A Recombinant human alpha-fetoprotein and uses thereof |
| 04/15/1998 | CN1178837A Fermentation method for preparing acabose by osmosis control |
| 04/14/1998 | US5739381 Disodium 4-chlorophenylthiomethylenebisphosphonate monohydrate, its preparation and pharmaceutical compositions in which it is present |
| 04/14/1998 | US5739345 Intermediate compounds in the preparation of heterocyclic compounds having anti-diabetic activity |
| 04/14/1998 | US5739338 Skin disorders, antiinflammatory agents, antitumor agents, vision defects, viricides, immunosuppressants |
| 04/14/1998 | US5739322 Process for preparing BIS-indolyl macrocycles |
| 04/14/1998 | US5739300 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/14/1998 | US5739167 Desferrioxamine-B salts and their use as orally effective iron chelators |
| 04/14/1998 | US5739147 Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases |
| 04/14/1998 | US5739138 Modulators of cellular response |
| 04/14/1998 | US5739135 Inhibitors of microsomal triglyceride transfer protein and method |
| 04/14/1998 | US5739117 Treatment of brain disorders resulting from reduced capacity of active glucose transport through blood-brain barrier |
| 04/14/1998 | US5739113 Injecting a composition comprising a bioactive material selected from prostaglandin e, growth hormone and growth factors and a controlled release matrix; expands, softens and restores elasticity |
| 04/14/1998 | US5739106 Appetite regulating compositions |
| 04/14/1998 | US5739032 Isolated nucleic acid encodes a glycoprotein for treating leukocyte adhesion deficiency |
| 04/14/1998 | US5739009 Adipocyte-specific differentiation-related protein |
| 04/14/1998 | US5738878 Purification, isolation by eluting with aqueous methanol solution; liquid chromatography |
| 04/14/1998 | US5738876 Method of solution overcoating with gelling polymer |
| 04/14/1998 | CA2015473C Triphenylmethane derivatives |
| 04/10/1998 | CA2217810A1 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
| 04/10/1998 | CA2217373A1 Benzo¬b|thiophene compounds, intermediates, formulations, and methods |
| 04/10/1998 | CA2217235A1 Benzo¬b|thiophene compounds, intermediates, formulations, and methods |
| 04/10/1998 | CA2217135A1 Benzo-b-thiophene compounds, intermediates, formulations, and methods |
| 04/09/1998 | WO1998014571A1 Human sulfonylurea receptor surh |
| 04/09/1998 | WO1998014568A1 Human growth gene and short stature gene region |
| 04/09/1998 | WO1998014478A1 Continuous low-dose administration of parathyroid hormone or its agonist |
| 04/09/1998 | WO1998014203A1 A method and compositions for treatment of insulin-dependant diabetes mellitus |
| 04/09/1998 | WO1998014177A1 Methods and compositions employing red yeast fermentation products |
| 04/09/1998 | DE19637518A1 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung PTX-sensitive G-proteins, their production and use |
| 04/09/1998 | CA2647169A1 Human growth gene and short stature gene region |
| 04/09/1998 | CA2267340A1 Methods and compositions employing red yeast fermentation products |
| 04/09/1998 | CA2267097A1 Human growth gene and short stature gene region |
| 04/09/1998 | CA2267063A1 A method and compositions for treatment of insulin-dependant diabetes mellitus |
| 04/09/1998 | CA2265466A1 Human sulfonylurea receptor surh |
| 04/08/1998 | EP0833913A1 Antigen non-specific glycosylation inhibiting factor derivatives |
| 04/08/1998 | EP0833823A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands |
| 04/08/1998 | EP0833670A2 Rotavirus enterotoxin nsp4 and methods of using same |
| 04/08/1998 | EP0833664A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b 4? receptor antagonist for the treatment of inflammations |
| 04/08/1998 | EP0833629A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 04/08/1998 | EP0833625A1 Method for regulating glucose metabolism |
| 04/08/1998 | EP0833624A2 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 04/08/1998 | EP0833622A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 04/08/1998 | EP0715624B1 Process for the preparation of benzodiazepine compounds useful as antagonists of cck or of gastrine |
| 04/08/1998 | EP0512042B1 Glp-1 analogs useful for diabetes treatment |
| 04/07/1998 | US5736575 Administering theanine (l-glutamic acid-gamma-ethylamide) to a mammal; stimulants |
| 04/07/1998 | US5736556 Parkinson*s disease; antidepressants; antiobesity; antinarcolepsy; drug abruse |
| 04/07/1998 | US5736554 Treating and/or preventing cardiovascular disorders |
| 04/07/1998 | US5736549 Hypoxanthine and guanine compounds |
| 04/07/1998 | US5736510 Antibiotics 10381v, w, x,y, z1, z2, pre-b and t |
| 04/07/1998 | US5736400 Method for modifying, diagnosing and screening for IGF-I sensitive cell barriers |
| 04/07/1998 | US5736337 Inhibiting protein interactions |
| 04/02/1998 | WO1998013384A1 Insulin c-peptides |
| 04/02/1998 | WO1998013354A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 04/02/1998 | WO1998013056A1 Beta-glucan products and extraction processes from cereals |
| 04/02/1998 | WO1998013053A1 Mistletoe (viscum) extracts |
| 04/02/1998 | WO1998013034A1 Use of sibutramine analogues to lower lipid levels |
| 04/02/1998 | DE19639375A1 Mistel-Trockenextrakte Mistletoe dried extracts |
| 04/02/1998 | CA2266929A1 Beta-glucan products and extraction processes from cereals |
| 04/01/1998 | EP0832891A1 Dihydrobenzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods |
| 04/01/1998 | EP0832890A1 Benzo (B) indeno (2,1-D) thiophene compounds, intermediates, processes, compositions, and methods |
| 04/01/1998 | EP0832888A1 Benzothiophene compounds, compositions, and methods |
| 04/01/1998 | EP0832883A1 Tetrahydrobenzo(a)fluorene compounds and methods of use |
| 04/01/1998 | EP0832882A2 Naphthofluorene compounds, intermediates, compositions, and methods |
| 04/01/1998 | EP0832881A2 Benzofluorene compounds, intermediates, compositions, and methods |
| 04/01/1998 | EP0832880A1 Dihydrobenzofluorene compounds, intermediates, compositions, and methods |
| 04/01/1998 | EP0832651A1 Inhibitor for lipid peroxide increase |
| 04/01/1998 | EP0832225A1 Chimeric proteins for use in transport of a selected substance into cells |
| 04/01/1998 | EP0832219A2 Chimeric leptin fused to immunoglobulin domain and use |
| 04/01/1998 | EP0832204A1 Treatment of insulin resistance |
| 04/01/1998 | EP0832112A1 Monocyte chemotactic protein-4 |
| 04/01/1998 | EP0832082A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 04/01/1998 | EP0832081A1 Bicyclic-aromatic compounds |
| 04/01/1998 | EP0832076A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 04/01/1998 | EP0832074A1 Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists |
| 04/01/1998 | EP0832066A1 Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| 04/01/1998 | EP0832063A1 Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 04/01/1998 | EP0832061A1 Benzamide derivatives and their use as vasopressin antagonists |